Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients

Clinical trial NCT06249152 · COMPLETED

Trial details

NCT number: NCT06249152
Sponsor: Qlaris Bio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)Glaucoma

Start date: 2024-04-21
Primary completion: 2024-12-20
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.